You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DDR

Showing 1 - 25 of 173
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Adult Trial in Amsterdam (AZD1390 + radiotherapy, AZD7648 + radiotherapy)

Recruiting
  • Soft Tissue Sarcoma Adult
  • AZD1390 + radiotherapy
  • AZD7648 + radiotherapy
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Aug 29, 2022

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

Bile Duct Cancer, Chemo Effect Trial in Seoul (AZD6738, Durvalumab, Olaparib)

Recruiting
  • Bile Duct Cancer
  • Chemotherapy Effect
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2021

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Head and Neck Squamous Cell Carcinoma Trial in France, Taiwan, United States (Ceralasertib, Olaparib)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Pittsburgh, Pennsylvania
  • +3 more
Aug 9, 2021

Colonic Diverticulitis Trial (quality of life)

Not yet recruiting
  • Colonic Diverticulitis
  • quality of life
  • (no location specified)
Aug 16, 2021

Advanced Solid Tumor, Breast Cancer Trial (Niraparib, M4344)

Withdrawn
  • Advanced Solid Tumor
  • Breast Cancer
  • (no location specified)
Jun 24, 2021

Breast Cancer, Brain Metastases, Adult Trial in Birmingham, Chapel Hill, Durham (Olaparib, Stereotactic Radiosurgery,

Not yet recruiting
  • Breast Cancer
  • Brain Metastases, Adult
  • (no location specified)
Oct 25, 2021

Pancreatic Ductal Adenocarcinoma Trial in Milan (Chlorambucil, Oral, 2 Mg)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Chlorambucil, Oral, 2 Mg
  • Milan, Italy
    IRCCS San Raffaele
Dec 30, 2020

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Dasatinib)

Withdrawn
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jul 17, 2020

DDR Gene Mutation, Metastatic Solid Tumor Trial in Seoul (Nivolumab)

Unknown status
  • DDR Gene Mutation
  • Metastatic Solid Tumor
  • Seoul, Chongro-ku, Korea, Republic of
  • +1 more
Feb 16, 2021

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Metastatic Pancreatic Cancer Trial in Barcelona, La Coruña, Santander (olaparib+durvalumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Barcelona, Spain
  • +2 more
Dec 29, 2022

Breast Tumor Trial in United Kingdom (AZD6738, Olaparib, Durvalumab)

Recruiting
  • Breast Neoplasm
  • Bournemouth, Dorset, United Kingdom
  • +8 more
Feb 19, 2020

Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)

Recruiting
  • Prostate Cancer
  • talazoparib plus enzalutamide
  • Placebo plus enzalutamide
  • Birmingham, Alabama
  • +306 more
Jan 18, 2023

Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Palo Alto, California
  • +15 more
Jan 6, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +3 more
  • (no location specified)
Jan 18, 2023

Ovarian Cancer, Breast Cancer, Solid Tumor Trial in Houston, Brisbane (CYH33)

Recruiting
  • Ovarian Cancer
  • +4 more
  • New Haven, Connecticut
  • +6 more
Oct 10, 2022

Orthopedics, Traumatology Trial in Vienna (Intravenous Infusion of Aclasta®)

Recruiting
  • Orthopedics
  • Traumatology
  • Intravenous Infusion of Aclasta®
  • Vienna, Austria
    Jakob Schanda
Jan 10, 2023

Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or

Completed
  • Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
  • Avelumab Phase 1b
  • +3 more
  • Fayetteville, Arkansas
  • +57 more
Jan 18, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • (no location specified)
Jan 14, 2023

Out-Of-Hospital Cardiac Arrest, Cardiopulmonary Arrest Trial in Vienna (Checklist for evaluation of reversible causes)

Not yet recruiting
  • Out-Of-Hospital Cardiac Arrest
  • Cardiopulmonary Arrest
  • Checklist for evaluation of reversible causes
  • Vienna, Austria
  • +1 more
Mar 13, 2023

Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023